{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:35:34Z","timestamp":1778009734473,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.molimm.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T12:41:33Z","timestamp":1581943293000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Glatiramer acetate protects against oxygen-glucose deprivation\/reperfusion-induced injury by inhibiting Egr-1 in H9c2 cells"],"prefix":"10.1016","volume":"120","author":[{"given":"Jian","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.molimm.2020.02.003_bib0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00054725-200502000-00003","article-title":"Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis","volume":"11","author":"Aharoni","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"issue":"12","key":"10.1016\/j.molimm.2020.02.003_bib0010","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1167\/iovs.11-7498","article-title":"Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer\u2019s disease","volume":"52","author":"Bakalash","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1-2","key":"10.1016\/j.molimm.2020.02.003_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2009.11.016","article-title":"Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis","volume":"219","author":"Begum-Haque","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"August (2)","key":"10.1016\/j.molimm.2020.02.003_bib0020","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2005.09.022","article-title":"Association of TNF-\u03b1 serum levels and TNFA promoter polymorphisms with risk of myocardial infarction","volume":"187","author":"Bennet","year":"2006","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.molimm.2020.02.003_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/156652407780059131","article-title":"ICAM-1 in acute myocardial infarction: a potential therapeutic target","volume":"7","author":"Benson","year":"2007","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.molimm.2020.02.003_bib0030","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/sctm.16-0114","article-title":"Targeted genome engineering to control VEGF expression in human umbilical cord blood\u2010derived mesenchymal stem cells: Potential implications for the treatment of myocardial infarction","volume":"6","author":"Cho","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"2","key":"10.1016\/j.molimm.2020.02.003_bib0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1582-4934.2006.tb00407.x","article-title":"Protein carbonylation, cellular dysfunction, and disease progression","volume":"10","author":"Dalle\u2010Donne","year":"2006","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.molimm.2020.02.003_bib0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI8970","article-title":"Glatiramer acetate (Copaxone\u00ae) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis","volume":"105","author":"Duda","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.molimm.2020.02.003_bib0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/1352458508088918","article-title":"Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone\u00ae)","volume":"14","author":"Iarlori","year":"2008","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.molimm.2020.02.003_bib0050","article-title":"Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk","volume":"12","author":"Ingrid","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.molimm.2020.02.003_bib0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.23938","article-title":"GALA Study Group. Three times weekly glatiramer acetate in relapsing\u2013remitting multiple sclerosis","volume":"73","author":"Khan","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.molimm.2020.02.003_bib0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2040-7378-6-4","article-title":"Glatiramer acetate does not protect from acute ischemic stroke in mice","volume":"6","author":"Kleinschnitz","year":"2014","journal-title":"Exp. Transl. Stroke Med."},{"issue":"11","key":"10.1016\/j.molimm.2020.02.003_bib0065","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40263-018-0567-8","article-title":"Impact of glatiramer acetate on B cell-mediated pathogenesis of multiple sclerosis","volume":"32","author":"Kuerten","year":"2018","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.molimm.2020.02.003_bib0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/11588120-000000000-00000","article-title":"Glatiramer acetate in the treatment of multiple sclerosis","volume":"25","author":"Lalive","year":"2011","journal-title":"CNS Drugs"},{"issue":"April","key":"10.1016\/j.molimm.2020.02.003_bib0075","first-page":"3","article-title":"Glatiramer acetate reduces infarct volume in diabetic mice with cerebral ischemia and prevents long-term memory loss","author":"Mangin","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.molimm.2020.02.003_bib0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7555\/JBR.28.20140037","article-title":"GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats","volume":"29","author":"Meng","year":"2015","journal-title":"J. Biomed. Res."},{"issue":"1","key":"10.1016\/j.molimm.2020.02.003_bib0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/15701611113119990003","article-title":"Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction","volume":"13","author":"Neri","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.molimm.2020.02.003_bib0090","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/WNL.56.6.702","article-title":"Mechanisms of action of glatiramer acetate in multiple sclerosis","volume":"56","author":"Neuhaus","year":"2001","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.molimm.2020.02.003_bib0095","doi-asserted-by":"crossref","first-page":"H278","DOI":"10.1152\/ajpheart.00471.2017","article-title":"VEGF nanoparticles repair the heart after myocardial infarction","volume":"314","author":"Oduk","year":"2017","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"9","key":"10.1016\/j.molimm.2020.02.003_bib0100","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00213-014-3791-z","article-title":"Involvement of nitric oxide in improving stress-induced behavioural alteration by glatiramer acetate treatment in female BALB\/c mice","volume":"232","author":"Pascuan","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.molimm.2020.02.003_bib0105","unstructured":"Sela Y, Marom E, Kimelman NB, inventors; Mapi pharma Ltd, assignee. Sublingual delivery of glatiramer acetate. United States patent application US 15\/126,362. 2017 Mar 23."},{"issue":"3","key":"10.1016\/j.molimm.2020.02.003_bib0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cei.12125","article-title":"Glatiramer acetate attenuates the pro\u2010migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis","volume":"173","author":"Sellner","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2020.02.003_bib0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2015.12.022","article-title":"Knockdown of TNF-\u03b1 by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction","volume":"83","author":"Somasuntharam","year":"2016","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.molimm.2020.02.003_bib0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"issue":"7058","key":"10.1016\/j.molimm.2020.02.003_bib0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.molimm.2020.02.003_bib0130","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/82168","article-title":"Stern DM. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress","volume":"6","author":"Yan","year":"2000","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.molimm.2020.02.003_bib0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1159\/000107547","article-title":"The protective effects of Nn-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rats by inhibiting Egr-1 overexpression","volume":"20","author":"Zhang","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"issue":"suppl_1","key":"10.1016\/j.molimm.2020.02.003_bib0140","doi-asserted-by":"crossref","first-page":"A333-","DOI":"10.1161\/atvb.37.suppl_1.333","article-title":"Hhcy promotes myocardial infarction induced myocardiocyte death via mitochondria mediated inflammasome activation","volume":"37","author":"Zhou","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019307084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019307084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:33:52Z","timestamp":1758980032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019307084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":28,"alternative-id":["S0161589019307084"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.02.003","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glatiramer acetate protects against oxygen-glucose deprivation\/reperfusion-induced injury by inhibiting Egr-1 in H9c2 cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}